PubMed COVID-19 Clinical Care

CONCLUSION: Given the ongoing strain and demand of COVID-19 on the healthcare system, a centralized, multi-disciplinary team of experts allowed for efficient delivery of COVID-19 therapies through one provider touchpoint. The collaboration between

CONCLUSION: The combined fluvoxamine treatment did not add benefit in preventing deterioration in mild-to-moderate COVID-19 patients without the immunomodulatory effect observed, although it demonstrated low hospitalization rates, oxygen supplemental

CONCLUSION: Based on NMA results, we suggest that CBT, which is the most commonly used digital technology, should be preferred among digital psychotherapy for relieving depression and anxiety symptoms. Digital exercise therapy is an effective

In the period of the corona virus disease 2019 (COVID-19) outbreak, an alcohol-based hand sanitizer is one of the most in-demand products for disinfection purposes. Two major concerns are adulteration of methanol, which causes toxicity to human

No abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) infection can cause fatal pulmonary inflammatory disease in humans. Contrarily, camelids and bats are the main reservoir hosts, tolerant for MERS-CoV replication without suffering clinical

Hiring nurses during and after the coronavirus disease 2019 (COVID-19) pandemic was challenging because of limited availability of travel nurses and a decreased volume of experienced RNs, particularly in specialty areas. A tailored on-boarding and

CONCLUSIONS: We observed no clinical benefit from PP among spontaneously breathing patients with COVID-19 pneumonia requiring conventional oxygen therapy.

Protocols for the isolation of peripheral blood mononuclear cells (PBMCs) from whole blood vary greatly between laboratories, especially in published studies of SARS-CoV-2-specific T cell responses following infection and vaccination. Research on the

No abstract